Israel Englander Amgen Inc Put Options Transaction History

Millennium Management LLC

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 14, 2024	BUY	$262.75 - $319.31 $25.7 Million - $31.2 Million	97,800 Added 20.04%	585,800 $183 Million
Q1 2024 May 15, 2024	BUY	$268.87 - $324.56 $6.96 Million - $8.41 Million	25,900 Added 5.6%	488,000 $139 Million
Q4 2023 Feb 14, 2024	SELL	$255.7 - $288.46 $80.4 Million - $90.7 Million	-314,300 Reduced 40.48%	462,100 $133 Million
Q2 2023 Aug 14, 2023	BUY	$214.27 - $253.37 $34.9 Million - $41.2 Million	162,800 Added 26.53%	776,400 $172 Million
Q1 2023 May 15, 2023	BUY	$225.79 - $275.2 $24.5 Million - $29.8 Million	108,400 Added 21.46%	613,600 $148 Million
Q4 2022 Feb 14, 2023	BUY	$229.03 - $291.01 $27.9 Million - $35.4 Million	121,700 Added 31.73%	505,200 $133 Million
Q3 2022 Nov 14, 2022	BUY	$224.46 - $253.15 $18.5 Million - $20.8 Million	82,200 Added 27.28%	383,500 $86.4 Million

3,075

417M

7.19M

6.29M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $170B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.